(6R,8aS)-6-(8-amino-1-bromoimidazo[1,5-a]pyrazin-3-yl)hexahydroindolizin-3(2H)-one, 96%, 250mg

Ethyl (11bR)-4-Amino-2,6-bis(3,5-di-tert-butylphenyl)-4,5-dihydro-3H-cyclohepta[1,2-a:7,6-a']dinaphthalene-4-carboxylate>97.0%(HPLC)50mg

5-Bromo-2-chloro-1,3-thiazole-4-carboxylic acid, 95+%, 100mg

tert-Butyl 2-formyl-4h,5h,6h,7h-thieno[3,2-c]pyridine-5-carboxylate, 95+%, 2.5g

Ethyl picolinoylacetate, 95.0%, 25g

1,2-Propanediol, min. 99.5%, for synthesis, 2.5 l, plastic packaging.

Methyl 2-Oxo-2H-pyran-5-carboxylate, 97.0%, 5g

4-Amino-3-nitrothiobenzamide, 100mg

tert-Butyl 1,7-diazaspiro[3.5]nonane-7-carboxylate hydrochloride, 98+%, 1g

Ethyl 2-chloronicotinate, 95.0%, 500g

7-BROMO-5-METHYL-1H-INDAZOLE, 95%, 5g

2-Ethynylpyridin-3-amine, 97%, 5g

1-tert-Butyl 3-Ethyl 4-Oxopyrrolidine-1,3-dicarboxylate>97.0%(HPLC)(N)5g